False-Positive Troponins: Clinical Misclassification, Delayed Recognition, and Health Care Costs in a Real-World Cohort
- 11 September 2026
- journal article
- Published by Elsevier in Heart, Lung and Circulation
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Macrotroponin: A Case Series and Review of the LiteratureHeart, Lung and Circulation, 2025
- Exploring strategies to rapidly identify false positives in high-sensitivity cardiac troponin I assay: A prospective studyClinica Chimica Acta, 2024
- Circulating Macrotroponin Complexes and Their Impact on Cardiac Troponin MeasurementsJACC: Cardiooncology, 2024
- Macrotroponin in the COVID-19 Era: An Under-Recognised Cause of Persistent Troponin ElevationHeart, Lung and Circulation, 2024
- Methods for analyzing positive cardiac troponin assay interferenceClinical Biochemistry, 2023
- Macrotroponin Probably Contributes to a Difference in Patient Stratification in Suspected Acute Coronary SyndromesJACC, 2021
- Fourth Universal Definition of Myocardial Infarction (2018)JACC, 2018
- Heterophilic antibody interference in immunometric assaysBest Practice & Research Clinical Endocrinology & Metabolism, 2013
- The exciting story of cardiac biomarkers: From retrospective detection to gold diagnostic standard for acute myocardial infarction and moreClinica Chimica Acta, 2006
- Characterization of Anti-heart Antibodies in Mice after Infection with Coxsackie B3 VirusClinical Immunology, 1999